SCHEMBL2016569

SCHEMBL2016569

O=CCc1c(-c2cccc(F)c2)cc(Cl)c2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.36
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35
GABRB2 P47870 2/20 0.35
GABRA4 P48169 2/20 0.35
GABRE P78334 2/20 0.35
GABRA6 Q16445 2/20 0.35
GABRG1 Q8N1C3 2/20 0.35
GABRG3 Q99928 2/20 0.35
GABRQ Q9UN88 2/20 0.35
LMNA P02545 2/20 0.35
HPGD P15428 1/20 0.35
CDK4 P11802 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013052 0.80 TAAR1 (0.47) NT5ECDC7ROCK2MAP4K4PIM1
SCHEMBL2015782 0.78 NT5E (0.36) NT5EGABRPGABRDGABRA1GABRB1
SCHEMBL1515905 0.72 MAOB (0.40) LMNAHPGDCDK4CCND1HTT
SCHEMBL2011676 0.68 KDM4E (0.41) NT5EGABRPGABRDGABRA1GABRB1
SCHEMBL2015005 0.68 PIK3CD (0.44) LMNAHPGDCDC7ROCK2MAP4K4
SCHEMBL24315366 0.67 CYP2A6 (0.58) LMNAHPGDCLK4MEN1KMT2A
SCHEMBL19287091 0.66 TAAR1 (0.65) SRCTAAR1DRD2
SCHEMBL31464089 0.65 CYP2A6 (0.50) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL2013731 0.65 AR (0.36) MEN1KMT2ADPP4KDM4EADORA2A
SCHEMBL2718869 0.65 NT5E (0.47) NT5EHPGDCDC7ROCK2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed